Back to results
WithdrawnPhase 3

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

NCT02106364

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Rheumatology Associates PC

Birmingham, Alabama, United States

+9 additional locations

View on ClinicalTrials.gov
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus — TrialFind